A new market study, titled “Psoriasis Treatment Market Forecast 2021-2028” has been featured on Fortune Business Insights™.
***Get Latest Updated Market Research Report with Free Sample Report
The global psoriasis treatment market size is projected to reach USD 40.58 billion by the end of 2027. Increasing focus on development of biologics for psoriasis treatment will aid the growth of the overall market in the coming years. According to a report published by Fortune Business Insights, titled “Psoriasis Treatment Market Size, Share & Covid-19 Impact Analysis, By Drug Class (TNF inhibitors, Interleukins, and Others), By Type (Plaque Psoriasis, Psoriatic Arthritis, and Others), By Route of Administration (Oral, Parenteral/Systemic, and Topical) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2020-2027,” the market was worth USD 20.09 billion in 2019 and will exhibit a CAGR of 9.2% during the forecast period, 2020-2027.
Psoriasis is a medical condition that directly affects the human skin. The condition is a long term disease that currently has very few or no treatment options. The severity of the disease and inadequate treatment methods will lead to a high emphasis on early detection and treatment of the disease across the world. The increasing research and development activities and high investments in these activities will create several growth opportunities for the companies operating in the market. The symptoms of psoriasis include red patches, itchiness, rashes, and irritation. The increasing medical activities associated with the condition and the growing emphasis on the development of efficient treatment options will emerge in favor of the growth of the overall psoriasis treatment market in the foreseeable future.
Request for Free Sample Report PDF @ https://www.fortunebusinessinsights.com/enquiry/sample/psoriasis-treatment
List of companies profiled in the report:
- AbbVie Inc. (Illinois, United States)
- Novartis AG (Basel, Switzerland)
- Johnson & Johnson Services, Inc. (New Jersey, United States)
- Pfizer Inc., (New York, United States)
- LEO Pharma A/S (Ballerup, Denmark)
- Merck & Co., Inc. (New Jersey, United States)
- Amgen Inc. (California, United States)
- Eli Lilly and Company (Indiana, United States)
- CELGENE CORPORATION (New Jersey, United States)
- UCB S.A. (Brussels, Belgium)
- Sun Pharmaceutical Industries Ltd. (Mumbai, India)
- Other prominent players
May 2019 –Mayne Pharma Group Limited announced that it has received FDA approval for the use of SORILUX Foam for the treatment of plaque psoriasis. The product is used in treatment of psoriasis of the body & scalp in patients aged 12 years and older.
NOTE : Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. We aim to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]